Mostafa Alfishawy - Infectious Diseases

Author Information

Mostafa Alfishawy is associated with the Infectious Diseases Consultants and Academic Researchers of Egypt (IDCARE), located in Cairo, Egypt. His work primarily focuses on infectious diseases, with a keen interest in the implications of COVID-19 and related health conditions.

Research Contributions

Mostafa Alfishawy has made significant contributions in the field of infectious diseases, particularly in the context of COVID-19. His research spans various aspects of the pandemic, including the efficacy of different cardiac rehabilitation methods, the potential protective role of measles IgG antibodies during the COVID-19 pandemic, and the relationship between diabetes mellitus and COVID-19. Additionally, he has explored the challenges of treating Staphylococcus aureus septic arthritis and antibiotic use and resistance among healthcare providers in Egypt. His work is notable for addressing the complexities of COVID-19-related complications, such as rhabdomyolysis following vaccination, massive gastrointestinal bleeding, and the challenges of antithrombotic therapy in COVID-19 patients.

Aliases

Mostafa Alfishawy is also known by the aliases M Alfishawy and M. Alfishawy in academic and research publications.

Publication and Citation Metrics

Metric	Value
Citation Count	432
h-index	12
Paper Count	39

Publications:

Comparative Assessment of the Long-Term Efficacy of Home-Based Versus Center-Based Cardiac Rehabilitation

DOI: 10.7759/cureus.23485

Year: 2022

Measles IgG Antibodies: Is There a Protective Role in COVID 19 Pandemic?‎ ‎

DOI: 10.21608/aeji.2021.72615.1144

Year: 2021

New-onset Type 1 Diabetes Mellitus with Diabetic Ketoacidosis and Pancreatitis in a Patient with COVID-19

DOI: 10.1016/j.sciaf.2021.e00915

Year: 2021

COVID-19 vaccine induced rhabdomyolysis: Case report with literature review

DOI: 10.1016/j.dsx.2021.06.007

Year: 2021

Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study

DOI: 10.7717/peerj.10910

Year: 2021

Diabetes Mellitus and COVID-19: Review Article

DOI: 10.1016/j.dsx.2021.102268

Year: 2021

Massive gastrointestinal bleeding in a patient with COVID-19

DOI: 10.1016/j.ajg.2021.05.008

Year: 2021

Risk Factors, Screening, and Treatment Challenges in Staphylococcus aureus Native Septic Arthritis

DOI: 10.1093/ofid/ofaa593

Year: 2021

Antibiotic Use and Resistance Among Prescribers: Current Status of Knowledge, Attitude, and Practice in Egypt

DOI: 10.2147/IDR.S299453

Year: 2021

Thrombosis in Covid-19 Patients and Dilemma of Antithrombotic Choice: A Systematic Review

DOI: 10.12691/EDUCATION-9-3-5

Year: 2021

What are Serological Tests?

What Do Blood Test Results Mean?

What are Common Adverse Effects of Antimicrobial Drugs?

How Do Imaging Tests Aid in Treatment?

How is Fatigue Diagnosed in the Context of Infectious Diseases?

How is HFMD Transmitted?

How does ELISA work?

Are There Any Risks Associated with Stool Sample Collection?

What are the Symptoms of E. Coli Infection?

Which Infectious Diseases Can Be Transmitted?

Partnered Content Networks

Relevant Topics